The fund was located in Asia if to be more exact in Taiwan. The main department of described VC is located in the Taipei.
The usual cause for the fund is to invest in rounds with 8 partakers. Despite the TSC BioVenture Capital Corporation, startups are often financed by Sycamore Ventures. The meaningful sponsors for the fund in investment in the same round are MDS Capital, United Investments, TVM Capital. In the next rounds fund is usually obtained by Sycamore Ventures, Lumira Ventures, iD Ventures America.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2006. The fund is constantly included in less than 2 deals per year.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight RenaMed Biologics. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Women's, Biotechnology.
|16M||27 Jun 2007||United Kingdom, " United Kingdom"}|
|40M||07 Sep 2006||United States, " United States"}|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.